Literature DB >> 31778741

Feedback-controlled photolytic gas phase nitric oxide delivery from S-nitrosothiol-doped silicone rubber films.

Gergely Lautner1, Orsolya Lautner-Csorba2, Blake Stringer2, Mark E Meyerhoff3, Steven P Schwendeman4.   

Abstract

Constant therapeutic gas phase nitric oxide (NO) delivery is achieved from S-nitrosothiol (RSNO) type NO donor doped silicone rubber films using feedback-controlled photolysis. For photo-release of the NO gas, the intensity of the LED light source is controlled via a PID (proportional-integral-derivative) controller implemented on a microcontroller. The NO concentration within the emitted gas phase is monitored continuously with a commercial amperometric NO gas sensor. NO release was accurately adjustable up to 10 ppm across a broad range of setpoints with response times of roughly 1 min or less. When NO is generated into an air recipient stream, lower NO yields and a comparable level of toxic nitrogen dioxide (NO2) formation is observed. However, NO gas generated into an N2 recipient gas stream can be blended into pure O2 with very low NO2 formation. Following scale-up, this technology could be used for point-of-care gas phase NO generation as an alternative for currently used gas cylinder technology for treatment of health conditions where inhaled NO is beneficial, such as pulmonary hypertension, hypoxemia, and cystic fibrosis.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Feedback control; Inhalation NO therapy; NO; Nitric oxide; S-nitrosothiol

Mesh:

Substances:

Year:  2019        PMID: 31778741      PMCID: PMC7895313          DOI: 10.1016/j.jconrel.2019.11.030

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  29 in total

1.  Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears.

Authors:  Richard Long; Richard Jones; James Talbot; Irvin Mayers; James Barrie; Michael Hoskinson; Bruce Light
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 2.  Antimicrobial and antiseptic strategies in wound management.

Authors:  Georg Daeschlein
Journal:  Int Wound J       Date:  2013-12       Impact factor: 3.315

3.  Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

Authors:  J D Roberts; J R Fineman; F C Morin; P W Shaul; S Rimar; M D Schreiber; R A Polin; M S Zwass; M M Zayek; I Gross; M A Heymann; W M Zapol
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

4.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

5.  Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy.

Authors:  Binglan Yu; Stefan Muenster; Aron H Blaesi; Donald B Bloch; Warren M Zapol
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

6.  Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine.

Authors:  Mark A Lovich; David H Fine; Ryan J Denton; Matt G Wakim; Abraham E Wei; Mikhail Y Maslov; Lucas G Gamero; Gregory B Vasquez; Bryan J Johnson; Robert F Roscigno; Richard J Gilbert
Journal:  Nitric Oxide       Date:  2014-02-07       Impact factor: 4.427

7.  Electrochemically modulated nitric oxide (NO) releasing biomedical devices via copper(II)-Tri(2-pyridylmethyl)amine mediated reduction of nitrite.

Authors:  Hang Ren; Jianfeng Wu; Chuanwu Xi; Nicolai Lehnert; Terry Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  ACS Appl Mater Interfaces       Date:  2014-03-14       Impact factor: 9.229

Review 8.  Exhaled nitric oxide as a biomarker in COPD and related comorbidities.

Authors:  Mario Malerba; Alessandro Radaeli; Alessia Olivini; Giovanni Damiani; Beatrice Ragnoli; Paolo Montuschi; Fabio L M Ricciardolo
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

9.  Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.

Authors:  Robert P Howlin; Katrina Cathie; Luanne Hall-Stoodley; Victoria Cornelius; Caroline Duignan; Raymond N Allan; Bernadette O Fernandez; Nicolas Barraud; Ken D Bruce; Johanna Jefferies; Michael Kelso; Staffan Kjelleberg; Scott A Rice; Geraint B Rogers; Sandra Pink; Caroline Smith; Priya S Sukhtankar; Rami Salib; Julian Legg; Mary Carroll; Thomas Daniels; Martin Feelisch; Paul Stoodley; Stuart C Clarke; Gary Connett; Saul N Faust; Jeremy S Webb
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

10.  Factors influencing decision making in neonatology: inhaled nitric oxide in preterm infants.

Authors:  Veena Manja; Gordon Guyatt; Satyan Lakshminrusimha; Susan Jack; Haresh Kirpalani; John A F Zupancic; Dmitry Dukhovny; John J You; Sandra Monteiro
Journal:  J Perinatol       Date:  2018-10-23       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.